Company profile
FinVector company profile
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for the production of gene therapy products for clinical and commercial supply.
Business identity
- Website
- http://www.finvector.com/
- Phone number
- +4407795065336
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00101-00250 employees
- Revenue range
- $10K+
- Founded
- 1993-01-01
Headquarters
- Headquarters
- Kuopio, North Savo, Finland
- Country code
- FI
- Continent
- Europe